fbpx
QQQ
-0.10
342.73
-0.03%
DIA
+ 3.97
328.99
+ 1.19%
SPY
+ 3.51
411.41
+ 0.85%
TLT
-2.06
147.79
-1.41%
GLD
+ 1.26
163.67
+ 0.76%

10 Biggest Price Target Changes For Monday

April 27, 2020 8:28 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
  • Morgan Stanley lowered the price target for American Express Company (NYSE:AXP) from $117 to $113. American Express closed at $83.17 on Friday.
  • B of A Securities boosted the price target on AptarGroup, Inc. (NYSE:ATR) from $101 to $131. AptarGroup closed at $104.12 on Friday.
  • Needham cut Splunk Inc (NASDAQ:SPLK) price target from $181 to $168. Splunk closed at $128.63 on Friday.
  • Citigroup raised the price target for Quest Diagnostics Inc (NYSE:DGX) from $113 to $130. Quest Diagnostics shares closed at $106.62 on Friday.
  • SVB Leerink reduced the price target on ABIOMED, Inc. (NASDAQ:ABMD) from $220 to $175. ABIOMED closed at $168.52 on Friday.
  • UBS lowered Beyond Meat Inc (NASDAQ:BYND) price target from $90 to $73. Beyond Meat shares closed at $108.78 on Friday.
  • MKM Partners raised the price target for Papa John's Int'l, Inc. (NASDAQ:PZZA) from $64 to $70. Papa John's closed at $72.00 on Friday.
  • BMO Capital cut Sealed Air Corp (NYSE:SEE) price target from $43 to $30. Sealed Air shares closed at $28.49 on Friday.
  • RBC Capital boosted the price target for Autoliv Inc. (NYSE:ALV) from $64 to $74. Autoliv shares closed at $60.75 on Friday.
  • Rosenblatt raised the price target for IDEX Corporation (NYSE:IEX) from $160 to $172. IDEX shares closed at $152.72 on Friday.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

10 Biggest Price Target Changes For Thursday

KeyBanc boosted Autodesk, Inc. (NASDAQ: ADSK) price target from $210 to $223. Autodesk closed at $199.81 on Wednesday. read more

10 Biggest Price Target Changes For Friday

Deutsche Bank Initiates Coverage On Abiomed with Buy Rating, Announces Price Target of $360

Deutsche Bank analyst Pito Chickering initiates coverage on Abiomed (NASDAQ:ABMD) with a Buy rating and announces Price Target of $360. read more

Morgan Stanley Maintains Underweight on Abiomed, Raises Price Target to $245

Morgan Stanley maintains Abiomed (NASDAQ:ABMD) with a Underweight and raises the price target from $238 to $245. read more